Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

208 projects found matching your search criteria :

  1. Exploring Antimicrobial Potential of Mytilus Genomic Resources

    Call: OPUS 29 , Panel: NZ8

    Principal investigator: prof. Artur Stanisław Burzyński

    Instytut Oceanologii PAN

  2. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

  3. Electrospun plant-based polymer patches for hormones and probiotics multistage targeted delivery

    Call: OPUS 29 , Panel: ST11

    Principal investigator: prof. Urszula Stachewicz

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  4. Characterization of microscopic fungi isolated from human cadavers.

    Call: PRELUDIUM 24 , Panel: NZ8

    Principal investigator: Klaudyna Aleksandra Spychała

    Uniwersytet Wrocławski

  5. "Green" Bioactive Dual-Layer Dressing for Controlled Neurotrophin and Analgesic Release to Support Nerve Regeneration in...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Anna Beata Zakrzewska

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  6. High Internal Phase Pickering Emulsions Stabilized with Solid Particles for Encapsulation of Lipophilic Drugs and Oxygen...

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Weronika Adriana Kieres

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  7. Structural engineering of cell-penetrating peptides into biostable antibacterials to combat drug-resistant pathogens

    Call: OPUS 29 , Panel: NZ1

    Principal investigator: prof. Joanna Dominika Trylska

    Uniwersytet Warszawski

  8. Pharmaceuticals in Sediments: Effects on Benthic Organisms under Climate Change Scenarios (SEDIPHARM)

    Call: OPUS 29 , Panel: NZ8

    Principal investigator: dr hab. Joanna Giebułtowicz

    Warszawski Uniwersytet Medyczny

  9. Therapeutic evaluation of anti-fibrotic agents for thyroid eye disease (TED) in a preclinical mouse model

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Paweł Franciszek Tyrna

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  10. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  11. Could fibroblast senescence and their resistance to apoptosis be the hidden drivers behind endometrial fibrosis in equin...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr Katarzyna Karolina Piotrowska-Tomala

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  12. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  13. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  14. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. Biological activity of AmB: Are the dynamics of interaction with the cell membrane the key?

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Sebastian Janik

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

  16. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Monika Katarzyna Rola

    Politechnika Łódzka

  17. The role of gut microbiota in the treatment of epilepsy: experimental studies

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

  18. Innovative organocatalytic strategies in functionalization of drugs, natural products and biological compounds.

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Kamil Dawid Hanek

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  19. EGR1 Protein: A Key Factor in Cellular Homeostasis?

    Call: PRELUDIUM 23 , Panel: NZ3

    Principal investigator: Marta Leśniczak-Staszak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  20. Stealth" asparaginases as improved protein drugs for the treatment of childhood acute lymphoblastic leukemia (ALL)

    Call: OPUS 27 , Panel: NZ1

    Principal investigator: prof. Matthias Bochtler

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  21. Impact of cytostatic drugs present in the environment on Gram-negative bacteria: mechanisms of adaptation and implicatio...

    Call: PRELUDIUM 23 , Panel: NZ9

    Principal investigator: Adam Grzywaczyk

    Politechnika Poznańska

  22. Analytical methods for the determination of contaminants in dairy products using electrochemical multisensors platform w...

    Call: DAINA 3 , Panel: NZ7

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  23. Eutectic composition as an innovative approach for tackling the limited physical stability problem of amorphous pharmace...

    Call: OPUS 26 , Panel: ST5

    Principal investigator: prof. Marian Wilhelm Paluch

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

  24. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  25. Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Pogoda

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  26. The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi...

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

  27. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Gabriela Małgorzata Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

  28. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  29. Virus lipid envelopes and their physicochemical description - towards the novel strategies to combat viruses.

    Call: SONATA BIS 13 , Panel: ST4

    Principal investigator: dr hab. Dorota Matyszewska

    Uniwersytet Warszawski, Wydział Chemii

  30. The EU system of regulatory exclusivities and rewards - towards a better-balanced legal framework of access to healthcar...

    Call: OPUS 25 , Panel: HS5

    Principal investigator: dr Żaneta Zemła-Pacud

    Instytut Nauk Prawnych PAN

  31. Interactions of non-steroidal anti-inflammatory drugs (NSAIDs) with photosynthetic apparatus as an essential factor of t...

    Call: PRELUDIUM 22 , Panel: NZ8

    Principal investigator: Monika Majewska

    Uniwersytet Gdański, Wydział Biologii

  32. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  33. The role of ubiquitination of L1 capsid protein in the Human Papillomavirus infection

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Justyna Karolina Broniarczyk

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  34. Chemosensors with molecularly imprinted polymers for determination of antiviral active drug substances in body fluids - ...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  35. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Jan Czesław Dobrowolski

    Narodowy Instytut Leków

  36. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  37. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Kinga Katarzyna Borowicz

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  38. The Power of Hybrid – Development of Novel Multienzymatic Cascade Reactions and Photo-Biocatalytic Redox Systems for Asy...

    Call: OPUS 24 , Panel: ST4

    Principal investigator: dr Paweł Borowiecki

    Politechnika Warszawska

  39. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  40. Biological roles of transcriptional networks activated in the brain by psychotropic drugs

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Michał Korostyński

    Instytut Farmakologii PAN

  41. New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  42. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon...

    Call: OPUS 22 , Panel: HS6

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

  43. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  44. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

  45. Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

  46. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

  47. Heterocyclization of benzenoid ansamycins core as useful strategy for designing anticancer agents

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Natalia Anna Skrzypczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  48. Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in pro...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  49. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Szymon Tomczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  50. The role of glycosylation of structural proteins in the life cycle of SARS-CoV-2 coronavirus.

    Call: OPUS 21 , Panel: NZ6

    Principal investigator: dr hab. Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy